The Technical AnalystExchange: JKT Sector: Healthcare Industry: Diagnostics & Research
PT Prodia Widyahusada Tbk Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.52% IDR3 230.00
America/New_York / 3 mai 2024 @ 05:05
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 028 125 mill |
| EPS: | 277.16 |
| P/E: | 11.65 |
| Earnings Date: | Mar 13, 2024 |
| SharesOutstanding: | 937.50 mill |
| Avg Daily Volume: | 1.022 mill |
| RATING 2024-05-03 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.18x |
| Company: PE 11.65 | sector: PE 65.62 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.82x |
| Company: PE 11.65 | industry: PE 14.25 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
IDR 3 124.03 - 3 335.97 ( +/- 3.28%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | IDR3 230.00 (-1.52% ) |
| Volume | 0.652 mill |
| Avg. Vol. | 1.022 mill |
| % of Avg. Vol | 63.79 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PRDA.JK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PRDA.JK
PT Prodia Widyahusada Tbk provides private clinical laboratory services. The company offers laboratory, panel test, and other diagnostics support services. As of December 31, 2021, it operated 259 outlets comprising 10 Prodia Health Care and specialty clinic outlets, 142 clinical lab and medical labs, 98 point of care outlets, and 9 hospital collaboration labs in 34 provinces throughout Indonesia. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk is a subsidiary of PT Prodia Utama.